Lucy Johnston

Lucy Johnston is a Health and Social Affairs Editor at the Sunday Express. She covers health policy, social care, and writes about problems in the NHS. She also focuses on social justice issues affecting older and younger generations. Lucy has won several awards for her investigative journalism on topics such as animal research, drug culture, mental health, and pharmaceutical industry practices.

70%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

  • Alzheimer's is a progressive and can be so fast.
  • ]A revolutionary jab, which is designed to remove toxic proteins from the brain before they cause the damage leading to the most common form of dementia, is undergoing trials on patients in the early stages of the disease.

Conflicts of Interest

50%

Examples:

  • ], scientists said the find was potentially a “massive breakthrough”. , Once through clinical trials scientists say it could be widely available within five years, preventing future generations from the misery of being struck down by Alzheimer's or seeing loved ones slowly diminish.

Contradictions

85%

Examples:

  • Leqembi goes into the brain and identifies building blocks that are toxic, trying to clear them out which slows down the progression of Alzheimer's disease and mitigates symptoms.

Deceptions

70%

Examples:

  • `A revolutionary jab, which is designed to remove toxic proteins from the brain before they cause the damage leading to the most common form of dementia, is undergoing trials on patients in the early stages of the disease.
  • `Last night scientists said the find was potentially a “massive breakthrough„.
  • `Once through clinical trials scientists say it could be widely available within five years, preventing future generations from the misery of being struck down by Alzheimer's or seeing loved ones slowly diminish.

Recent Articles

Revolutionary Jab and Medication Show Promising Results in Preventing Alzheimer's Disease

Revolutionary Jab and Medication Show Promising Results in Preventing Alzheimer's Disease

Broke On: Sunday, 31 March 2024 A revolutionary jab and a medication called Leqembi are undergoing trials for Alzheimer's disease. The new vaccine aims to stop damage before it occurs, while the medication slows progression in early stages of dementia. Both have mild side effects and could be widely available within five years if successful in clinical trials.